Agree. Thanks. I know it's not the same. Especially not informing the sponsor about the 'Evolving Science' in a timely manner. But that's more or less the fault of the reviewer or the FDA's internal procedures. the way this crooks have treated AMRN so far, i believe they would blame it on either reviewer or update their procedures (as directed by the Senate) rather than giving justice to AMRN.
News 
Market Data 
Discover 
AI
